Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q1 EPS of ($0.09), $0.21 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $6.4 million versus the consensus estimate of $4.99 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) click here.